Search Results 2611-2620 of 17718 for rheumatoid arthritis

  1. Spine Care - Doctors - Mayo Clinic

    Jacksonville, FL. Areas of focus: Regenerative medicine therapy, Ultrasound, Pain management, Back pain, Arthritis, Neck pain, Pain ...

  2. You Asked, We Answered - Alzheimer's Disease Research Center - Mayo Clinic Research

    Arthritis; Childhood asthma; Dementia; Erectile dysfunction and female sexual dysfunction; Frailty; Macular degeneration in people 60 years of age and older ...

  3. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

    ... factor alpha (TNFa) antagonists, or vedolizumab. Exclusion Criteria: Current complications of CD such as symptomatic strictures, severe rectal/anal stenosis ...

  4. A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma - Mayo Clinic

    Previous systemic anti-vascular endothelial growth factor (VEGF) or any prior systemic anti-cancer therapy, including prior treatment with systemic agents ...

  5. Orthopedic Oncology - Doctors - Mayo Clinic

    ... arthritis, Basilar skull invagination, Failed back syndrome. Show more areas of focus for Oluwaseun O. Akinduro, M.D.. Kimberly K ...

  6. Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma - Mayo Clinic

    Without growth factor support within 7 days (14 days if given pegfilgrastim) of screening;; Platelet transfusion is not permitted within 7 days of screening ...

  7. Sports medicine - Division of Orthopedic Surgery Research - Mayo Clinic Research

    Injectable orthobiologics. Autologous, culture-expanded mesenchymal stem cells for knee and hip arthritis in early-onset degenerative disease. Novel injectable ...

  8. Triamcinolone (injection route) - Mayo Clinic

    It is used to treat a number of different conditions, such as inflammation (swelling), severe allergies, adrenal problems, arthritis, blood or bone marrow ...

  9. A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants with Moderately to Severely Active Crohn's Disease (CD) - Mayo Clinic

    ... factor (TNF-IR). ... Prophylactic aspirin use up to 325 mg/day is permitted, as is occasional use of NSAIDs for conditions such as headache, arthritis, myalgia, ...

  10. Oncology (Medical) - Clinical trials

    Olaparib, cediranib maleate, and standard chemotherapy may work better in treating patients with small cell lung cancer. A Study of Leukemia Inhibitory Factor ...